Afyren SAS (ALAFY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Afyren SAS (ALAFY) has a cash flow conversion efficiency ratio of -0.044x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.74 Million ≈ $-3.20 Million USD) by net assets (€62.95 Million ≈ $73.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALAFY market cap overview for the company's overall valuation and market capitalisation.
Afyren SAS - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Afyren SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Afyren SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Afyren SAS ranked by their cash flow conversion efficiency. See Afyren SAS (ALAFY) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fine DNC Co. Ltd
KQ:049120
|
-0.052x |
|
Aspen Group Ltd
TA:ASGR
|
0.003x |
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
0.001x |
|
Chainqui Construction Development Co Ltd
TW:2509
|
-0.053x |
|
Oxford Square Capital Corp
NASDAQ:OXSQ
|
0.033x |
|
Gongin Precision Industrial Co Ltd
TWO:3178
|
0.072x |
|
Maxigen Biotech Inc
TW:1783
|
0.050x |
|
Nicola Mining Inc
V:NIM
|
0.542x |
Annual Cash Flow Conversion Efficiency for Afyren SAS (2019–2025)
The table below shows the annual cash flow conversion efficiency of Afyren SAS from 2019 to 2025. View ALAFY share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €62.95 Million ≈ $73.60 Million |
€-5.09 Million ≈ $-5.96 Million |
-0.081x | +24.17% |
| 2024-12-31 | €52.70 Million ≈ $61.61 Million |
€-5.62 Million ≈ $-6.57 Million |
-0.107x | -30.81% |
| 2023-12-31 | €61.80 Million ≈ $72.25 Million |
€-5.04 Million ≈ $-5.89 Million |
-0.082x | -75.66% |
| 2022-12-31 | €70.98 Million ≈ $82.98 Million |
€-3.30 Million ≈ $-3.85 Million |
-0.046x | -33.17% |
| 2021-12-31 | €77.86 Million ≈ $91.02 Million |
€-2.71 Million ≈ $-3.17 Million |
-0.035x | -76.37% |
| 2020-12-31 | €19.57 Million ≈ $22.88 Million |
€-387.00K ≈ $-452.44K |
-0.020x | +85.29% |
| 2019-12-31 | €5.51 Million ≈ $6.44 Million |
€-741.00K ≈ $-866.31K |
-0.134x | -- |
About Afyren SAS
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermo… Read more